[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Kharbanda R.K., Wallace S., Walton B., Donald A., Cross J.M., Deanfield J
One example escalation schedule observed in Phase 2 obesity trials proceeded broadly as follows: Weeks 14: 2 mg once weekly (initiation phase) Weeks 58: 4 mg once weekly Weeks 912: 8 mg once weekly Weeks 13 onwards: Up to 12 mg once weekly (the maximum dose explored in Phase 2 trials) This is an illustrative example only
Here's what we'll cover Key takeaways Semaglutide is a weekly injectable medication for type 2 diabetes, obesity, and some forms of heart disease, administered subcutaneously in the stomach, thigh, or upper arm
After customers complete health screenings, it connects them with health care providers who can write prescriptions, which are then filled by pharmacy partners
Chapman I, Parker B, Doran S, et al
Noticeable improvement in recovery within the first week